Triple-Negative Receptor Conversion at Metastatic Sites Might Show Better Efficacy in Patients Who Received Sacituzumab Govitecan.

Subjects

Subjects :

Humans
Antibodies, Monoclonal, Humanized therapeutic use
Camptothecin therapeutic use
Immunoconjugates

Details

Language :

English

ISSN :

1527-7755

Volume :

41

Issue :

8

Database :

MEDLINE

Journal :

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Publication Type :

Editorial & Opinion

Accession number :

36608300

Full Text :

https://doi.org/10.1200/JCO.22.01961